Rosen Center (Room: Executive H) | Supported By: AstraZeneca

---

Program Description

Eosinophilic granulomatosis with polyangiitis (EGPA) and hypereosinophilic syndrome (HES) are both rare types of eosinophilic disorders. Diagnosis and management of these disorders is challenging due to their complex and overlapping pathologic features and heterogeneous systemic involvement. Both disorders carry substantial risks of morbidity and mortality due to delayed diagnosis and inadequate treatment. Interleukin (IL)-5 is a key driver of pathophysiology; therapies targeting IL-5 or the IL-5 receptor are a mainstay of treatment.

In this confidence-based clinical decision CALIBRATE symposium, Drs. Praveen Akuthota, Philip Seo, and Michael Wechsler will discuss EGPA and HES patient cases with real-world, point-of-care decision checkpoints paired with confidence ratings to improve diagnosis and treatment sequencing.

Join us for dinner on SUN 5/17 6:30 PM at the Rosen Center (Executive H)

This program was developed by, or with financial support and influence from, Integritas Communications and is neither sponsored by nor endorsed by ATS.

Speakers

Presenter: Michael Wechsler, MD, MMSc
National Jewish Health
Department of Medicine
Professor
Denver, Colorado

Presenter: Praveen Akuthota, MD
University of California San Diego
Professor of Medicine
La Jolla, California

Presenter: Philip Seo, MD, MHS
Johns Hopkins University School of Medicine
Associate Professor of Medicine
Baltimore Maryland